Gene · 92521
Papers3,158
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,361 to 1,380 of 3,158
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Binary-QSAR guided virtual screening of FDA approved drugs and compounds in clinical investigation against SARS-CoV-2 main protease. | Turk J Biol | 2021 | 34803447 | PubTator, text mining | PubMed |
| In silico drug repositioning against human NRP1 to block SARS-CoV-2 host entry. | Turk J Biol | 2021 | 34803446 | PubTator, text mining | PubMed |
| 2-((1H-indol-3-yl)thio)-N-phenyl-acetamides: SARS-CoV-2 RNA-dependent RNA polymerase inhibitors. | Antiviral Res | 2021 | 34801588 | PubTator, text mining | PubMed |
| Perspectives on SARS-CoV-2 Main Protease Inhibitors. | J Med Chem | 2021 | 34798775 | PubTator, text mining | PubMed |
| Multidimensional Mutational Profiling of the Indian HNSCC Sub-Population Provides IRAK1, a Novel Driver Gene and Potential Druggable Target. | Front Oncol | 2021 | 34796107 | PubTator, text mining | PubMed |
| Inhibitor of growth protein 3 epigenetically silences endogenous retroviral elements and prevents innate immune activation. | Nucleic Acids Res | 2021 | 34791430 | PubTator, text mining | PubMed |
| Running With Scissors: Evolutionary Conflicts Between Viral Proteases and the Host Immune System. | Front Immunol | 2021 | 34790204 | PubTator, text mining | PubMed |
| All hands on deck: SARS-CoV-2 proteins that block early anti-viral interferon responses. | Curr Res Virol Sci | 2021 | 34786565 | PubTator, text mining | PubMed |
| Regulation of antiviral innate immune signaling and viral evasion following viral genome sensing. | Exp Mol Med | 2021 | 34782737 | PubTator, text mining | PubMed |
| Porcine epidemic diarrhea virus nsp14 inhibits NF-κB pathway activation by targeting the IKK complex and p65. | Anim Dis | 2021 | 34778885 | PubTator, text mining | PubMed |
| Immunopathology and Immunopathogenesis of COVID-19, what we know and what we should learn. | Gene Rep | 2021 | 34778602 | PubTator, text mining | PubMed |
| Nanomaterial Based Biosensors for Detection of Viruses Including SARS-CoV-2: A Review. | J Anal Test | 2021 | 34777896 | PubTator, text mining | PubMed |
| Innate Immunity Evasion Strategies of Highly Pathogenic Coronaviruses: SARS-CoV, MERS-CoV, and SARS-CoV-2. | Front Microbiol | 2021 | 34777324 | PubTator, text mining | PubMed |
| Integrative Multi-omics Landscape of Non-structural Protein 3 of Severe Acute Respiratory Syndrome Coronaviruses. | Genomics Proteomics Bioinformatics | 2021 | 34774773 | PubTator, text mining | PubMed |
| Structural and functional significance of the amino acid differences Val35Thr, Ser46Ala, Asn65Ser, and Ala94Ser in 3C-like proteinases from SARS-CoV-2 and SARS-CoV. | Int J Biol Macromol | 2021 | 34774600 | PubTator, text mining | PubMed |
| RNA-binding protein IGF2BP2 enhances circ_0000745 abundancy and promotes aggressiveness and stemness of ovarian cancer cells via the microRNA-3187-3p/ERBB4/PI3K/AKT axis. | J Ovarian Res | 2021 | 34774079 | PubTator, text mining | PubMed |
| Structural and Biochemical Analysis of the Dual Inhibition of MG-132 against SARS-CoV-2 Main Protease (Mpro/3CLpro) and Human Cathepsin-L. | Int J Mol Sci | 2021 | 34769210 | PubTator, text mining | PubMed |
| Genomic characterization of an African G4P[6] human rotavirus strain identified in a diarrheic child in Kenya: Evidence for porcine-to-human interspecies transmission and reassortment. | Infect Genet Evol | 2021 | 34767977 | PubTator, text mining | PubMed |
| Diagnosis of Streptococcus pneumoniae infection using circulating antibody secreting cells. | PLoS One | 2021 | 34767590 | PubTator, text mining | PubMed |
| Nano-therapeutic strategies to target coronavirus. | View (Beijing) | 2021 | 34766165 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/92521/papers?page=69